The EASL Podcast collection brings together Talk Liver to Me , EASL’s exclusive original podcast, alongside educational audio content adapted from EASL Studio, DeepDive webinars, and Policy Dialogues. Stay informed with expert insights, practical discussions, and the latest knowledge in hepatology — anytime, anywhere.
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Public web form
Booking probability
34%
Guest openness
Selective
Sign up to generate a grounded pitch for EASL Podcasts.
Signup to Generate a PitchThe EASL Podcast collection brings together Talk Liver to Me, EASL’s exclusive original podcast, alongside educational audio content adapted from EASL Studio, DeepDive webinars, and Policy Dialogues. Stay informed with expert insights, practical discussions, and the latest knowledge in hepatology, anytime, anywhere.
Recent episodes include "Talk Liver To Me - Hepatocellular Carcinoma: Who to screen, when, and how?" (28 October 2026, 38 minutes), "Talk Liver To Me - Psychohepatology: Are we overlooking mental health in liver disease care?" (14 October 2026, 38 minutes), and "Resmetirom and Semaglutide in MASH: Who, when and how to monitor?" (30 September 2026, 44 minutes).
EASL Podcasts publishes roughly every two weeks, with episodes averaging 47 minutes across 165 episodes.
Booking probability for EASL Podcasts is 34%, and the host is rated Selective on guests. EASL Podcasts requires a Pod Score of 80 or higher. EASL Podcasts's contact route on record: public web form.
The strongest fits for EASL Podcasts are Health & Wellness Services. EASL Podcasts has a health audience.
EASL Podcasts is a health podcast with 165 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #20
Hepatocellular carcinoma (HCC) surveillance is a cornerstone of liver disease management, yet uncertainty persists around who to screen, when to initiate surveillance, and which modalities to use. Evolving risk profiles...
Episode #19
This episode explores psychohepatology, examining the gut–liver–brain axis and the bidirectional links between liver disease and mental health. Discussion covers addiction biology, the impact of trauma and...
Episode #18
This episode of Talk Liver to Me explores the practical use of resmetirom and semaglutide in MASH, based on the 2026 EASL–EASD–EASO Guidance. Experts discuss who may benefit from treatment, when to initiate therapy, and...
Episode #17
Liver disease represents a major and under-recognised public health challenge across Africa, driven by a complex interplay of viral hepatitis, rising metabolic dysfunction-associated steatotic liver disease, and a high...
Episode #16
Acute liver failure (ALF) is a rare but life-threatening condition requiring rapid recognition and decisive management. Early decisions around investigation, escalation, and referral can significantly impact outcomes...
Episode #15
Endohepatology is emerging as a novel approach to liver disease assessment, with the potential to combine EUS-guided liver biopsy, portal pressure measurement, and variceal evaluation within a single session. This...
Episode #14
Early-career researchers and clinician-scientists play a central role in advancing hepatology research and innovation, yet the transition to independence often comes with challenges that extend beyond scientific...
Episode #13
Hepatitis E is a globally prevalent infection with diverse clinical manifestations, ranging from self-limiting acute hepatitis to chronic infection in immunosuppressed patients. Its presentation and epidemiology vary...
Episode #12
Metabolic dysfunction-associated steatotic liver disease (MASLD) and heart failure with preserved ejection fraction (HFpEF) are increasingly recognised as manifestations of a shared cardiometabolic disorder. Driven by...
EASL Podcasts
The following objectives will be addressed in this EASL Deep Dive episode: Have a profound knowledge of the pitfalls, limitations and difficulty of interpretation of the different tests of copper metabolism and liver...
Episode #11
Steatotic liver disease (SLD) research relies heavily on preclinical models, yet no single model can fully capture the complexity of human disease. In this episode, we explore the new EASL position paper on preclinical...
Episode #10
Haemochromatosis remains one of the most common inherited metabolic disorders, yet it is frequently underdiagnosed and inconsistently managed in clinical practice. With widespread use of iron studies and genetic...
Episode #9
In this episode, we discuss the first pig-to-human liver xenotransplantation and the breakthroughs behind the revival of xenotransplantation, examining its potential and remaining challenges. We also explore the...
Episode #8
Spontaneous bacterial peritonitis (SBP) remains a major complication of cirrhosis - but rising antimicrobial resistance and emerging data are challenging long-standing practices. In this episode, we review current...
EASL Podcasts
In this EASL DeepDive webinar, the expert panel presents and explains the key studies behind the latest recommendations included in the EASL Clinical Practice Guidelines on the management of extrahepatic...
Episode #7
This episode explores the role of lifestyle in preventing and managing liver disease, including MASLD/MASH. Our experts discuss the impact of diet and physical activity, why lifestyle change can be difficult to start...
EASL Podcasts
Hepatocellular carcinoma (HCC) is responsible for 75% of all primary liver cancers and is the third most prevalent cause of cancer death worldwide, with 900,000 new cases diagnosed each year. Many patients are diagnosed...
EASL Podcasts
In this EASL DeepDive, experts will discuss the latest advances in the EASL Clinical Practice Guidelines on the management of hepatitis B virus infection, published in the "Journal of Hepatology" in 2025. Learning...
EASL Podcasts
In this EASL DeepDive, experts will discuss the latest advances in the EASL Clinical Practice Guidelines on the management of autoimmune hepatitis, published in the "Journal of Hepatology" in 2025. Learning objectives...
EASL Podcasts
In this episode our speakers share their immediate impressions and break down the key highlights shaping the management of portal hypertension and advanced liver disease. What has truly changed in practice? Where was...
Recent guests on EASL Podcasts. Study who booked and why before you pitch.
Chair Of Insurance Ireland Flood Policy Taskforce Implementation Sub Group, Arabian Professional and Amateur Horseman's Association
professor and department chair of gastroenterology and hepatology, University of Southern Denmark
Professor of Biomedical Engineering, North Carolina State University and UNC Chapel Hill
Associate Professor, Weill Cornell Medicine
PitchCentric classifies EASL Podcasts under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ
